Know Your Herbs

The Future Of CBD Gummies In Canada

The future of CBD gummies in Canada in 2024 is shaping to be exciting and full of potential. With growing consumer interest and technological advancements, the market for CBD-infused products is expanding rapidly. Regulatory frameworks are evolving to ensure safety and quality, promoting a trustworthy environment for consumers and producers. However, current trends in CBD gummies include increasing demand for natural wellness products, innovations in flavors and formulations, stricter quality control measures, and more excellent…

Source: cc

The Global Medical Cannabis Explosion is Imminent

Recently, I have become more optimistic about the global landscape of medical cannabis and the direction in which major regulatory agencies are heading. Years of stifling regulatory environments and political headwinds that have hampered the cannabis industry seem to be giving way to real progress. Earlier this year, the United States Department of Health and Human Services (HHS) released a 252-page report stating that cannabis is safe. The health authority further noted that cannabis has…

Source: cc

Retail Cannabis Sales Growth Continues To Slow, Retail Stores Decrease

Retail cannabis sales rebounded in February and April after dropping to their lowest in nearly a year in January 2024, according to the most recent figures from Statistics Canada. Although cannabis sales in Canada still show year-over-year growth, the increase in those sales continues to slow as the market reaches a possible saturation point. Retail cannabis sales in Canada were $539 million in April 2024, after dropping to $518 million in January after the holiday…

Source: cc

Legal Cannabis Product Labeling Misses the Mark in Canada

Canada’s legalization of cannabis oil and other nonmedical cannabis products in 2018 has not led to better quality control and accurate product labeling, new research suggested. The first study of the label accuracy of cannabis oil products in the legal Canadian market found “discrepancies at multiple levels,” the authors wrote. One third of products purchased for the study differed from their online tetrahydrocannabinol (THC) and cannabidiol (CBD) descriptions, and 16.7% had conflicting information on the…

Source: cc